IMMUNIC, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Immunic, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q4 2024.
  • Immunic, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$25.2M, a 16.7% decline year-over-year.
  • Immunic, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$101M, a 7.37% decline year-over-year.
  • Immunic, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$101M, a 7.37% decline from 2023.
  • Immunic, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$93.6M, a 22.3% increase from 2022.
  • Immunic, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$120M, a 29.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$101M -$25.2M -$3.6M -16.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$96.9M -$24.4M -$1.6M -7.02% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$95.3M -$21.4M +$2.62M +10.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$97.9M -$29.6M -$4.31M -17.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$93.6M -$21.6M +$34.9M +61.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$129M -$22.8M -$1.55M -7.28% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$127M -$24M -$2.1M -9.58% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$125M -$25.3M -$4.46M -21.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$120M -$56.5M -$35.3M -167% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$85.1M -$21.2M -$1.93M -10% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$83.2M -$21.9M -$3.97M -22.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$79.2M -$20.8M +$13.7M +39.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$92.9M -$21.2M -$10M -89.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 -$82.9M -$19.3M -$6.38M -49.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$76.5M -$17.9M -$6.48M -56.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$70.1M -$34.5M -$26M -307% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$44M -$11.2M -$3.47M -45.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$40.5M -$12.9M -$4.7M -57.2% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 -$35.9M -$11.5M +$3.26M +22.1% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$39.1M -$8.49M -$4.17M -96.8% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 -$34.9M -$7.69M -$2.88M -59.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$32.1M -$8.22M -$6.42M -357% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 -$25.6M -$14.7M -$12M -451% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 -$13.6M -$4.31M -$2.05M -90.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 -$11.5M -$4.81M +$9.78M +67% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$21.3M -$1.8M +$10.7M +85.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$32M -$2.67M +$9.74M +78.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$41.7M -$2.26M +$10.3M +82% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$52.1M -$14.6M -$2.85M -24.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-04
Q3 2017 -$49.2M -$12.5M -$2.3M -22.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-04
Q2 2017 -$46.9M -$12.4M -$2.94M -31% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-04
Q1 2017 -$44M -$12.6M -$3.01M -31.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-04
Q4 2016 -$41M -$11.7M -$1.88M -19% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-04
Q3 2016 -$39.1M -$10.2M +$2.12M +17.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 -$41.2M -$9.47M +$5.64M +37.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$46.9M -$9.59M +$5.17M +35% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$52M -$9.86M +$4.1M +29.3% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-08
Q3 2015 -$56.1M -$12.3M +$498K +3.89% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$56.6M -$15.1M -$4.94M -48.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$51.7M -$14.8M -$4.01M -37.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$47.7M -$14M -$3.72M -36.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$44M -$12.8M -$5.82M -83.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 -$38.1M -$10.2M -$4.02M -65.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 -$34.1M -$10.7M -$1.39M -14.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
Q4 2013 -$32.7M -$10.2M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-20
Q3 2013 -$6.98M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-20
Q2 2013 -$6.14M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-20
Q1 2013 -$9.36M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.